Skip to main content

Table 3 Baseline clinical predictors of outcome in among People with HIV (PWH, n = 270)

From: Clinical features and outcomes of COVID-19 admissions in a population with a high prevalence of HIV and tuberculosis: a multicentre cohort study

Parameter

Survivors

n = 199 (73.7%)

Non-survivors

n = 71 (26.3%)

RR (95% CI)

P value

On ART (n = 214)

153 (71.5%)

61 (28.5%)

0.90 (0.79–1.01)

0.11

Not on ART (n = 56)

46 (82.1%)

10 (17.9%)

Current TB (n = 29)

18 (62.1%)

11 (37.9%)

1.52 (0.91–2.55)

0.13

Previous TB (n = 37)

25 (67.6%)

12 (32.3%)

1.28 (0.77–2.14)

0.36

Overweight (n = 79)

59 (74.7%)

20 (25.3%)

1.95 (.0.61–1.48)

0.81

Diabetes (n = 73)

52 (71.2%)

21 (28.8%)

1.13 (0.73–1.75)

0.57

Hypertension (n = 103)

71 (68.9%)

32 (31.1%)

1.33 (0.89–1.98)

0.16

  1. ART  antiretroviral treatment, TB  tuberculosis, RR risk ratio